Clinical Trial Update: AZD2281 and Cisplatin Plus Gemcitabine to Treat Solid Tumor Cancers [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating AZD2281 (olaparib) in combination with cisplatin and gemcitabine for solid tumors; study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• AZD2281 (olaparib)
• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Neoplasms | Phase 1 | Status: COMPLETED